0000950170-23-028297.txt : 20230615 0000950170-23-028297.hdr.sgml : 20230615 20230615161942 ACCESSION NUMBER: 0000950170-23-028297 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Arcus Biosciences, Inc. CENTRAL INDEX KEY: 0001724521 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473898435 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38419 FILM NUMBER: 231017605 BUSINESS ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 694-6200 MAIL ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Tang Carolyn C. CENTRAL INDEX KEY: 0001836662 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 144 1 primary_doc.xml 144 0001836662 XXXXXXXX LIVE 0001724521 Arcus Biosciences, Inc. 001-38419 3928 Point Eden Way Hayward CA 94545 (510)-694-6200 Carolyn Tang Officer COMMON E*TRADE FINANCIAL CORPORATION

3 EDISON DRIVE ALPHARETTA GA 30005

3500 70000 73105580 06/16/2023 NYSE COMMON 06/15/2023 Vesting of restricted stock granted 6/5/2020 Arcus Biosciences, Inc. N 8250 06/15/2023 Services rendered Y The reported transactions represent mandatory sell-to-cover transactions effected pursuant to the Issuer's equity administration policy. 06/15/2023 01/15/2021 /s/ Carolyn Tang